Arcturus Therapeutics
ARCT
#8778
Rank
โ‚น19.89 B
Marketcap
โ‚น690.39
Share price
-1.97%
Change (1 day)
23.10%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2026 (TTM): -โ‚น8.47 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚น18.72 Million. In 2025 the company made an earning of -โ‚น6.1 Billion, an increase over its 2024 earnings that were of -โ‚น8.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น8.47 Billion38.88%
2025 -โ‚น6.1 Billion-28.73%
2024 -โ‚น8.56 Billion240.24%
2023 -โ‚น2.52 Billion-298.78%
2022 โ‚น1.26 B-106.79%
2021 -โ‚น18.63 Billion181.83%
2020 -โ‚น6.61 Billion183.72%
2019 -โ‚น2.33 Billion16.93%
2018 -โ‚น2 Billion154.5%
2017 -โ‚น0.79 Billion-65.36%
2016 -โ‚น2.27 Billion25.93%
2015 -โ‚น1.8 Billion-41.04%
2014 -โ‚น3.05 Billion219.64%
2013 -โ‚น0.96 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-97.65% Bahamas
NRC Health
NRC
โ‚น1.37 B-116.11%๐Ÿ‡บ๐Ÿ‡ธ USA